サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China

CountryFocus:中国における医療、規制、および医療費償還制度の展望

レポート概要

本レポートは、中国における医療、規制、および医療費償還制度の展望に関する情報や分析に不可欠な情報を提供し、医療市場における主要動向を明らかにします。また、人口動態、規制、医療費償還制度の展望、および医療インフラに関する見識を提供します。さらに、製薬および医療機器市場の動向やセグメントに関する貴重な情報を提供します。 本レポートは、業界の専門家からなる自社チームによる独自のデータベース、一次調査と二次調査、および自社分析を基にしたデータや情報を盛り込んでいます。

西洋医薬品、医薬品原料(API)、伝統的な中国医薬(TCM)、生物製剤および漢方薬の製造を含む中国の製薬業界は、2010年に1,686億ドルと評価され、2016年には4,246億ドルに成長しました。西洋医学の医薬品市場は538億ドルの価値があり、2016年にはCAGR 12%で1,060億ドルに増加しました。そして2018年の1,329億ドルから、2022ねんには2,090億ドルへと成長する見込みです。中国の医療機器市場は、2015年には360億ドルと評価され、2017年には401億ドルに成長しました。2015年以降、中国食品医薬品局(CFDA)は、 医薬品市場を改革するためのいくつかの政策を発表しました。臨床試験プロセスの改革は研究開発のコストと時間を削減するのに役立ちましたが、市場承認プロセスのイニシアチブは規制の遅れを最小限に抑えるのに役立ちました。

■調査範囲

  • 市場規模、市場セグメント、主要推進要因、および障壁など、中国における製薬および医療機器市場の概説
  • 主要企業のプロファイルとSWOT分析
    ➣ 主要製薬企業:Pfizer、Merck、Novartis、Jiangsu Hengrui Medicine、Sinopharm、Tong Ren Tang
    ➣ 主要医療機器企業:Medtronic、Abbott、Roche、Boston Scientific、Shinva
  • 中国の医薬品および医療機器市場における最近完了した取引に関する詳細な分析
  • 中国の医薬品・医療機器市場におけるPorter’s five forces分析
  • ヘルスケア償還プロセス、規制機関、新薬および医療機器の承認プロセスの詳細を含む、償還および規制状況の洞察を深めたレビュー
  • 最近の医療政策、医療インフラおよび医療費に関する情報
  • 中国の医療市場における成長の機会と成長の課題の概要

レポート詳細

目次

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Biosimilars in Development by Chinese Companies, China, 2016
Table 2: Top 5 Therapeutic Areas by Incidence Rate (per 100,000 person), China, 2016
Table 3: Ophthalmic Devices Market, China, Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 4: Orthopedic Devices Market, China, Revenue ($m) and Market Share (%) of Major Companies, 2017
Table 5: Diagnostic Imaging Devices Market, China, Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 6: Nephrology and Urology Devices Market, China, Revenue ($m) and Market Share (%) of Major Companies, 2016
Table 7: Cardiovascular Devices Market, China, Revenue ($m) and Market Share (%) of Major Companies, 2017
Table 8: Drug Classification System, China, 2017
Table 9: Medical Device Classification, China, 2016
Table 10: Trademark Process Timeline, China, 2017
Table 11: Documents for Advertising Application, China, 2017
Table 12: Label/Insert Sheet Information, China, 2017
Table 13: Key Improvement Indicators, Healthy China 2030
Table 14: Trade Fairs, China, 2018-2019

List of Figures
Figure 1: Pharmaceutical Market, China, Revenue ($bn), 2010-2017
Figure 2: Medical Device Market, China, Revenue ($bn), 2015-2020
Figure 3: Country Profile, China, 2017
Figure 4: Pharmaceutical Market, China, Revenue ($bn), 2010-2017
Figure 5: Pharmaceutical Market, China, Revenue Forecast ($bn), 2018-2022
Figure 6: Pharmaceutical Exports ($bn), China, 2010-2017
Figure 7: Top Export Partners, China, 2017
Figure 8: Pharmaceutical Imports ($bn), China, 2010-2017
Figure 9: Top Import Partners, China, 2017
Figure 10: USTR Findings, 2018
Figure 11: US-China Trade War Timeline, 2018
Figure 12: Pharmaceutical Drug Sales Channel, China, 2016
Figure 13: Supply Chain Prior to 2017
Figure 14: Two Invoice System
Figure 15: Policies for Biosimilar Promotion, China, 2018
Figure 16: Major Biosimilar Sales ($m), China, 2016
Figure 17: Traditional Chinese Medicine Production (10,000 tons), China, 2010-2016
Figure 18: Top 5 Therapeutic Areas by Incidence Rate (per 100,000 person), China, 2016
Figure 19: Pharmaceutical Market, Major Players, 2017
Figure 20: Medical Device Market, China, Revenue ($bn), 2015-2020
Figure 21: Medical Device Market, China, Revenue Forecast ($bn), 2021-2025
Figure 22: Medical Device Market, China, Revenue by Segment ($bn), 2017
Figure 23: Ophthalmic Devices Market, China, Revenue ($m), 2015-2022
Figure 24: Ophthalmic Devices Market, China, Market Share of Major Players (%), 2015
Figure 25: Orthopedic Devices Market, China, Revenue ($m), 2015-2020
Figure 26: Orthopedic Devices Market, China, Market Share of Major Companies (%), 2017
Figure 27: Diagnostic Imaging Devices Market, China, Revenue ($bn), 2015-2020
Figure 28: Diagnostic Imaging Devices Market, China, Market Share of Major Players (%), 2015
Figure 29: Nephrology and Urology Devices Market, China, Revenue ($m), 2015-2022
Figure 30: Nephrology and Urology Devices Market, China, Market Share of Major Players (%), 2016
Figure 31: Cardiovascular Devices Market, China, Revenue ($bn), 2015-2022
Figure 32: Cardiovascular Devices Market, China, Market Share of Major Players (%), 2017
Figure 33: Diagnostic Market, China, Revenue ($bn), 2015-2020
Figure 34: Diagnostic Market, China, Revenue ($bn), 2021-2025
Figure 35: Medical Device Market, China, Revenue ($bn) of Major Companies, 2017
Figure 36: Deal Value and Deal Count, Pharmaceutical Market, China, 2017-2018
Figure 37: Deal Value and Deal Count Quarterly, Pharmaceutical Market, China, 2017-2018
Figure 38: Deal Value and Deal Count Sub-types, Pharmaceutical Market, China, 2017-2018
Figure 39: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, China, 2017-2018
Figure 40: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, China, 2017-2018
Figure 41: M&A Deals by Therapy Area, Pharmaceutical Market, China, 2017-2018 (by value and count)
Figure 42: Venture Financing Deals by Therapy Area, Pharmaceutical Market, China, 2017-2018 (by value and count)
Figure 43: Private Equity Deals by Therapy Area, Pharmaceutical Market, China, 2017-2018 (by value and count)
Figure 44: Medical Device Market Deals (by deal value, $bn), China, 2017-2018
Figure 45: Medical Device Market Deals (by deal count), China, 2017-2018
Figure 46: Medical Device Market Deals Share (by deal count), China, 2017-2018
Figure 47:Medical Device Market Deals Share (by deal value), China, 2017-2018
Figure 48: Medical Device, China, Top Therapy Area by Deal Value, 2017-2018
Figure 49: Medical Devices, China, M&A Deals by Therapy Area, 2017-2018
Figure 50: Medical Devices, China, Venture Financing Deals by Therapy Area, 2017-2018
Figure 51: Medical Devices, China, Top Therapy Area by Deal Number, 2017-2018
Figure 52: Medical Devices, China, Private Equity Deals by Therapy Area, 2017-2018
Figure 53: Healthcare System, China, 2017
Figure 54: National Reimbursement Drug List Process, China, 2017
Figure 55: National Reimbursement Drug List Classification, China, 2017
Figure 56: Public Insurance Schemes, China, 2017
Figure 57: Out-of-Pocket Expenditure (% of total expenditure on health), China, 2010-2017
Figure 58: Annual Rate of Change (%), Health Care Price Index, China, 2010-2016
Figure 59: Pricing Policies, China, 2017
Figure 60: Drug Movement from Market Authorization to Patient Use, China, 2016
Figure 61: Ministry of Food and Drug Safety, Organization Chart, 2017
Figure 62: Timeline of CFDA Reforms, China, 2015-2018
Figure 63: Center for Drug Evaluation Organization Chart, China, 2017
Figure 64: Drug Approval Process, China, 2017
Figure 65: Generic Drug Approval Process, China, 2017
Figure 66: Medical Device Approval Process, China, 2017
Figure 67: Patent Approval Process, China, 2016
Figure 68: Proposed Patent Linkage System, China, 2017
Figure 69: Trademark Process, China, 2017
Figure 70: Advertising Application Approval Process, China, 2017
Figure 71: Key Announcements and Updates, Healthy China 2020, 2009-2016
Figure 72: Healthy China 2030, Strategic Goals
Figure 73: Hospitals (Number), China, 2010-2017
Figure 74: Hospitals by Type (Number), China, 2010-2017
Figure 75: Diagnostic Equipment (installed base), China, 2015-2012
Figure 76: Hospital Beds (per 1,000 population), China, 2010-2017
Figure 77: Medical Institution Beds (Urban)(per 1,000 population), China, 2010-2017
Figure 78: Medical Institution Beds (Rural)(per 1,000 population), China, 2010-2017
Figure 79: Life Expectancy (in years), China, 2010-2017
Figure 80: Immunization Rate (%), China, 2010-2017
Figure 81: PM2.5 (μg per m3), China, 2010-2017
Figure 82: CO2 Emissions (metric tons per capita), China, 2010-2017
Figure 83: Physicians (per 1,000 population), China, 2010-2017
Figure 84: Nurses (per 1,000 population), China, 2010-2017
Figure 85: Dentists, (per 1,000 population), China, 2010-2017
Figure 86: Pharmacists, (per 1,000 population), China, 2010-2017
Figure 87: Major Causes of Mortality (Death rate (%)), China, 2016
Figure 88: Major Causes of Male Mortality (Death rate (%)), China, 2016
Figure 89: Major Causes of Female Mortality (Death rate (%)), China, 2016
Figure 90: Disability-Adjusted Life Years by Major Disease (‘000), China, 2015
Figure 91: Healthcare Expenditure as Percentage of GDP (%), China, 2010-2017
Figure 92: Public-Private Share (%), China, 2010-2017
Figure 93: Opportunities & Challenges, China

発刊日

2019/01/01

体裁

PDF / 140ページ

販売価格

1,995USD

発行

GlobalData

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品産業(医療制度、医療観光など)

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE